Southeast Asia-focused medtech firm secures $2.5m from Silicon Valley investors

Genetica, a US-based medtech startup that mainly provides its services in Southeast Asia, said it has raised US$2.5 million in its pre-series A raise, which it claims spanned only 30 days.

Tuan Cao, Genetica’s chief technology officer / Photo credit: Genetica

Seasoned Silicon Valley investors such as Greylock Partners’ Dave Strohm, Meritech partner and managing director Craig Sherman, and Miasnik Ventures CEO Guy Miasnik participated in the round. Between them, the three have backed companies such as Facebook, Airbnb, Salesforce, LinkedIn, and Athoc.

Genetica is an AI-enabled genomic testing company that analyzes and decodes genes to help with personalized nutrition, sickness prevention, and children’s development planning, among others.

The startup says it has received more than 10,000 users within a few months of its tech going to market, and it’s now eyeing 10x growth in 2021. In addition to the new funding, Genetica said it’s currently in talks with select VC funds that can help it expand in Asia for additional capital.

The company is looking “to partner with those who genuinely understand the technology and pursue positive social impact in a long-term manner,” said Genetica’s founders.

Genetica was established by chief technology officer Tuan Cao, chief science officer Duyen Bui, and chief experience officer Giang Pham. The three co-founders bring with them experience from companies such as Google, Mekong Capital, and the University of California.